These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
782 related articles for article (PubMed ID: 21300456)
1. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456 [TBL] [Abstract][Full Text] [Related]
2. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091 [TBL] [Abstract][Full Text] [Related]
3. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
4. pN0(i+) breast cancer: treatment patterns, locoregional recurrence, and survival outcomes. Karam I; Lesperance MF; Berrang T; Speers C; Tyldesley S; Truong PT Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):731-7. PubMed ID: 24035330 [TBL] [Abstract][Full Text] [Related]
5. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size. Fodor J; Polgár C; Major T; Németh G Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264 [TBL] [Abstract][Full Text] [Related]
6. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status. Yang PS; Chen CM; Liu MC; Jian JM; Horng CF; Liu MJ; Yu BL; Lee MY; Chi CW Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):516-22. PubMed ID: 19577858 [TBL] [Abstract][Full Text] [Related]
8. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215 [TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
11. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results]. Fodor J; Mózsa E; Zaka Z; Polgár C; Major T Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814 [TBL] [Abstract][Full Text] [Related]
12. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Truong PT; Lesperance M; Culhaci A; Kader HA; Speers CH; Olivotto IA Int J Radiat Oncol Biol Phys; 2005 May; 62(1):175-82. PubMed ID: 15850919 [TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040 [TBL] [Abstract][Full Text] [Related]
14. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574 [TBL] [Abstract][Full Text] [Related]
15. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Truong PT; Lee J; Kader HA; Speers CH; Olivotto IA Eur J Cancer; 2005 Jun; 41(9):1267-77. PubMed ID: 15939262 [TBL] [Abstract][Full Text] [Related]
16. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069 [TBL] [Abstract][Full Text] [Related]
17. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065 [TBL] [Abstract][Full Text] [Related]
18. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546 [TBL] [Abstract][Full Text] [Related]
19. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909 [TBL] [Abstract][Full Text] [Related]
20. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors. Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]